Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2008

01-10-2008 | Research Article

Oral chemotherapy in paediatric oncology in the UK: problems, perceptions and information needs of parents

Authors: Nanna Christiansen, Kevin M. G. Taylor, Catherine Duggan

Published in: International Journal of Clinical Pharmacy | Issue 5/2008

Login to get access

Abstract

Objective To identify problems, perceptions and information needs of parents and carers regarding oral chemotherapy. Setting Two Paediatric Oncology Centres in the UK. Methods A semi-structured questionnaire was developed in consultation with professionals working within paediatric oncology. Questionnaires were administered in face-to-face interviews with parents of patients attending clinic appointments. Responses to questions were coded and entered into a database for descriptive and inferential analyses. Responses to open questions were coded using simple thematic analysis whereby codes and themes emerged from the data and were compared and contrasted between respondents. Findings were further validated by quotes from interviewees to open questions. Main outcome measures Awareness and knowledge of medicines, information needs and handling procedures. Results Fifty-five interviews were conducted. Most interviewees viewed oral and intravenous chemotherapy as equally important and potent. Three-quarters of parents were aware of the adverse effects chemotherapy could have on them, worryingly three-quarters of the same group of parents did not use all the handling precaution methods advised by health care professionals. Knowledge of acute lymphoblastic leukaemia maintenance treatment was assessed in 47 interviewees; 31 parents were able to explain the reasons for maintenance chemotherapy. Interviewees felt well informed by the hospital and found it easy to access information they needed. The data suggest the majority of parents had a great interest in understanding the disease and treatment, with 91% using the internet to access further information. Three-quarters of parents faced some kind of difficulty when dealing with oral chemotherapy, including problems with the patient not taking the drug, technical and supply problems and problems following the drug regimen. Self-reported compliance in this study was high with 69.1% of interviewees stating they never forgot a single dose. 72.2% of interviewees used a reminder method, of which 81.6% were written reminders. Conclusion This study highlights that although the support systems offered by the paediatric oncology centres were good, certain areas need improvement, specifically the manner in which parents/carers are educated and informed.
Literature
1.
go back to reference Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 1999;93:2817–23.PubMed Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 1999;93:2817–23.PubMed
2.
go back to reference Schmiegelow K, Schroeder H, Gustafsson G, Kristinsson J, Glomstein A, Salmi T, et al. Risk of relapse in childhood acute lymphoblastic leukaemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Paediatric Haematology and Oncology. J Clin Oncol 1995;13:345–51.PubMed Schmiegelow K, Schroeder H, Gustafsson G, Kristinsson J, Glomstein A, Salmi T, et al. Risk of relapse in childhood acute lymphoblastic leukaemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Paediatric Haematology and Oncology. J Clin Oncol 1995;13:345–51.PubMed
3.
go back to reference Smith SD, Rosen D, Trueworthy RC, Lowman JT. A reliable method for evaluation drug compliance in children with cancer. Cancer 1979;43:169–73.PubMedCrossRef Smith SD, Rosen D, Trueworthy RC, Lowman JT. A reliable method for evaluation drug compliance in children with cancer. Cancer 1979;43:169–73.PubMedCrossRef
4.
5.
go back to reference Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J. Compliance of paediatric and adolescent cancer patients. Cancer 1986;58:1179–84.PubMedCrossRef Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J. Compliance of paediatric and adolescent cancer patients. Cancer 1986;58:1179–84.PubMedCrossRef
6.
go back to reference Lennard L, Lilleyman JS. Variable mercaptopurine metabolism and treatment outcomes in childhood lymphoblastic leukaemia. J Clin Oncol 1989;7:1816–23.PubMed Lennard L, Lilleyman JS. Variable mercaptopurine metabolism and treatment outcomes in childhood lymphoblastic leukaemia. J Clin Oncol 1989;7:1816–23.PubMed
7.
go back to reference Adams M. Information and education across the phases of cancer care. Semin Oncol Nurs 1991;7:105–11.PubMedCrossRef Adams M. Information and education across the phases of cancer care. Semin Oncol Nurs 1991;7:105–11.PubMedCrossRef
8.
go back to reference Bowling A. Research methods in health, 2nd ed. Buckingham: Open University Press; 2002. ISBN 0-335-20643-3. Bowling A. Research methods in health, 2nd ed. Buckingham: Open University Press; 2002. ISBN 0-335-20643-3.
9.
go back to reference Davies HA, Lennard L, Lillyman JS. Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? Br Med J 1993;306:1239–40.CrossRef Davies HA, Lennard L, Lillyman JS. Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? Br Med J 1993;306:1239–40.CrossRef
10.
go back to reference Haynes BH, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383–6.PubMedCrossRef Haynes BH, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383–6.PubMedCrossRef
Metadata
Title
Oral chemotherapy in paediatric oncology in the UK: problems, perceptions and information needs of parents
Authors
Nanna Christiansen
Kevin M. G. Taylor
Catherine Duggan
Publication date
01-10-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9208-5

Other articles of this Issue 5/2008

International Journal of Clinical Pharmacy 5/2008 Go to the issue

Conference Abstracts

UKCPA spring meeting 2007

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine